Cargando…

Meningococcal Vaccines: Challenges and Prospects

Detalles Bibliográficos
Autores principales:	Bagwe, Priyal, Bajaj, Lotika, Gala, Rikhav, Zughaier, Susu M., Uddin, Mohammad N., D’Souza, Martin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761900/ https://www.ncbi.nlm.nih.gov/pubmed/33291728 http://dx.doi.org/10.3390/vaccines8040738

Ejemplares similares

Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated Neisseria gonorrhoeae Microparticle Vaccine Formulation
por: Bagwe, Priyal, et al.
Publicado: (2022)

Microneedles: A New Generation Vaccine Delivery System
por: Menon, Ipshita, et al.
Publicado: (2021)

Novel Whole-Cell Inactivated Neisseria Gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization
por: Gala, Rikhav P., et al.
Publicado: (2018)

Enhanced Immunogenicity of an Influenza Ectodomain Matrix-2 Protein Virus-like Particle (M2e VLP) Using Polymeric Microparticles for Vaccine Delivery
por: Gomes, Keegan Braz, et al.
Publicado: (2022)

An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice
por: Vijayanand, Sharon, et al.
Publicado: (2023)

Exploring the Potential of T-Cells for a Universal Influenza Vaccine
por: Vijayanand, Sharon, et al.
Publicado: (2020)

Trends in Nonparenteral Delivery of Biologics, Vaccines and Cancer Therapies
por: D’Souza, Martin J., et al.
Publicado: (2015)

Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus
por: Vijayanand, Sharon, et al.
Publicado: (2022)

Zika Vaccine Microparticles (MPs)-Loaded Dissolving Microneedles (MNs) Elicit a Significant Immune Response in a Pre-Clinical Murine Model
por: Kale, Akanksha, et al.
Publicado: (2023)

Adjuvanted-SARS-CoV-2 Spike Protein-Based Microparticulate Vaccine Delivered by Dissolving Microneedles Induces Humoral, Mucosal, and Cellular Immune Responses in Mice
por: Patil, Smital, et al.
Publicado: (2023)

Vaccine-Induced Immunity Elicited by Microneedle Delivery of Influenza Ectodomain Matrix Protein 2 Virus-like Particle (M2e VLP)-Loaded PLGA Nanoparticles
por: Braz Gomes, Keegan, et al.
Publicado: (2023)

Subunit microparticulate vaccine delivery using microneedles trigger significant SARS-spike-specific humoral and cellular responses in a preclinical murine model
por: Patil, Smital, et al.
Publicado: (2023)

Potential Applications of Microparticulate-Based Bacterial Outer Membrane Vesicles (OMVs) Vaccine Platform for Sexually Transmitted Diseases (STDs): Gonorrhea, Chlamydia, and Syphilis
por: Chbib, Christiane, et al.
Publicado: (2021)

Peptide-Based Vaccines and Therapeutics for COVID-19
por: Bagwe, Pritam V., et al.
Publicado: (2022)

Commencement of the Meningococcal Vaccination for the Republic of Korea Army
por: Lee, Sang-Oh
Publicado: (2013)

Gonococcal Vaccine Development: Lessons from Group B Meningococcal Vaccines
Publicado: (2017)

Dissolving Microneedles Loaded with Nanoparticle Formulation of Respiratory Syncytial Virus Fusion Protein Virus-like Particles (F-VLPs) Elicits Cellular and Humoral Immune Responses
por: Menon, Ipshita, et al.
Publicado: (2023)

Buccal and Sublingual Vaccines: A Review on Oral Mucosal Immunization and Delivery Systems
por: Trincado, Valeria, et al.
Publicado: (2021)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

Meningococcal Disease
por: Pollard, Andrew J
Publicado: (2018)

Meningococcal Vaccinations
por: Crum-Cianflone, Nancy, et al.
Publicado: (2016)

Pneumococcal Vaccines: Challenges and Prospects
por: Licciardi, Paul, et al.
Publicado: (2019)

Meningococcal Vaccination:: An Update on Meningococcal Vaccine Recommendations for the Primary Care Physician
por: Nichols, Justin, et al.
Publicado: (2022)

Prospects for eradication of meningococcal disease
por: Nadel, Simon
Publicado: (2012)

An Overview of Current Accomplishments and Gaps of COVID-19 Vaccine Platforms and Considerations for Next Generation Vaccines
por: Kale, Akanksha, et al.
Publicado: (2023)

Editorial: Role of Iron in Bacterial Pathogenesis
por: Zughaier, Susu M., et al.
Publicado: (2018)

Vaccines against Meningococcal Diseases
por: Pizza, Mariagrazia, et al.
Publicado: (2020)

Impact of vaccination on meningococcal epidemiology
por: Stefanelli, Paola, et al.
Publicado: (2015)

Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa
por: Berlier, Monique, et al.
Publicado: (2015)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
por: Kimmel, Sanford R
Publicado: (2008)

Could Public Health Problem from Meningococcal Disease Be Eliminated?
por: Haileamlak, Abraham
Publicado: (2013)

Meningococcal Disease in Korea: an Epidemiologic Study of the Underestimated Infectious Disease
por: Heo, Jung Yeon
Publicado: (2016)

A new meningococcal B vaccine
por: Russo, Rocco
Publicado: (2014)

Vaccination strategies for the prevention of meningococcal disease
por: Vuocolo, Scott, et al.
Publicado: (2018)

Invasive Meningococcal Disease in the Vaccine Era
por: Nadel, Simon, et al.
Publicado: (2018)

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons
por: Enwere, Godwin C., et al.
Publicado: (2015)

Measuring meningococcal vaccination coverage among adolescents in Italy: state-of-the-art and regional challenges
por: Ferrara, Pietro, et al.
Publicado: (2022)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

Editorial: Immune-Modulatory Effects of Vitamin D
por: Zughaier, Susu M., et al.
Publicado: (2020)

Structure-Dependent Immune Modulatory Activity of Protegrin-1 Analogs
por: Zughaier, Susu M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t0lnjsfr2d29ddastin4snm79e